IVD Wiki from Genrui
Genrui is pleased to announce that selected Specific Protein assays used on the PA240 and PA480 Fully Automated Specific Protein Analyzers have successfully completed the 2026 External Quality Assessm...
Read More >WHX Labs Dubai 2026, one of the most influential and large-scale exhibitions for medical laboratory equipment and supplies in the Middle East.Genrui proudly showcased its presence at this prestigious ...
Read More >From November 17th to 20th, MEDICA—the world’s largest and most influential event in the medical industry—was successfully held in Düsseldorf, Germany. Renowned for its professionalism, scale, and...
Read More >Genrui is pleased to announce that selected Specific Protein assays used on the PA240 and PA480 Fully Automated Specific Protein Analyzers have successfully completed the 2026 External Quality Assessm...
WHX Labs Dubai 2026, one of the most influential and large-scale exhibitions for medical laboratory equipment and supplies in the Middle East.Genrui proudly showcased its presence at this prestigious ...
From November 17th to 20th, MEDICA—the world’s largest and most influential event in the medical industry—was successfully held in Düsseldorf, Germany. Renowned for its professionalism, scale, and...
Since 2004, Genrui Biotech Inc. has empowered customers to solve complex challenges and transform their businesses. As a high-tech company, we adapt and respond quickly to changes around us to deliver better solutions to impact the world.
Specialized in developing, manufacturing and marketing IVD instruments and reagents, we are the only company in China that is capable of providing both human and veterinary IVD products and solutions. With wide-ranging product lines: Hematology, Chemistry, Chemiluminescence, POCT, Molecule, Veterinary, Specific Protein as well as associated reagents, one of the market leaders in China and in more than 120 countries and regions have been built.
In 2014-2021, more than 20% of annual turnover was invested into R & D, with over 100 engineers and 200 independent patents.
Genrui has always attached great importance to innovation and development. We have built a global innovation exchange and practice platform and trained a large number of leading technical talents.
Genrui maintains long-term cooperation with experts in multiple fields around the world. With more insight and rapid feedback, we constantly provide innovative products and solutions to help improve the efficiency of IVD diagnosis and treatment and promote the development of cutting-edge research.
Genrui is pleased to announce that selected Specific Protein assays used on the PA240 and PA480 Fully Automated Specific Protein Analyzers have successfully completed the 2026 External Quality Assessm...
WHX Labs Dubai 2026, one of the most influential and large-scale exhibitions for medical laboratory equipment and supplies in the Middle East.Genrui proudly showcased its presence at this prestigious ...
From November 17th to 20th, MEDICA—the world’s largest and most influential event in the medical industry—was successfully held in Düsseldorf, Germany. Renowned for its professionalism, scale, and...